Ausgabe 6/2015
Inhalt (14 Artikel)
Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy
Peter F. Mulders, Maria De Santis, Thomas Powles, Karim Fizazi
Preclinical activity of anti-CCR7 immunotherapy in patients with high-risk chronic lymphocytic leukemia
Carlos Cuesta-Mateos, Javier Loscertales, Anna Kreutzman, Beatriz Colom-Fernández, Itxaso Portero-Sáinz, Juan José Pérez-Villar, Fernando Terrón, Cecilia Muñoz-Calleja
CEA/CD3-bispecific T cell-engaging (BiTE) antibody-mediated T lymphocyte cytotoxicity maximized by inhibition of both PD1 and PD-L1
Takuya Osada, Sandip P. Patel, Scott A. Hammond, Koya Osada, Michael A. Morse, H. Kim Lyerly
Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer
Sean G. Smith, Bhanu prasanth Koppolu, Sruthi Ravindranathan, Samantha L. Kurtz, Lirong Yang, Matthew D. Katz, David A. Zaharoff
CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma
Takumi Kumai, Toshihiro Nagato, Hiroya Kobayashi, Yuki Komabayashi, Seigo Ueda, Kan Kishibe, Takayuki Ohkuri, Miki Takahara, Esteban Celis, Yasuaki Harabuchi
Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response
Naoya Hashimoto, Akihiro Tsuboi, Naoki Kagawa, Yasuyoshi Chiba, Shuichi Izumoto, Manabu Kinoshita, Noriyuki Kijima, Yoshihiro Oka, Soyoko Morimoto, Hiroko Nakajima, Satoshi Morita, Junichi Sakamoto, Sumiyuki Nishida, Naoki Hosen, Yusuke Oji, Norio Arita, Toshiki Yoshimine, Haruo Sugiyama
Overexpression of apolipoprotein A-I fused to an anti-transforming growth factor beta peptide modulates the tumorigenicity and immunogenicity of mouse colon cancer cells
José Medina-Echeverz, Marcos Vasquez, Celia Gomar, Nuria Ardaiz, Pedro Berraondo
Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma
Laura K. Aguilar, Lawrence A. Shirley, Vincent M. Chung, Christopher L. Marsh, Jon Walker, Walter Coyle, Howard Marx, Tanios Bekaii-Saab, Gregory B. Lesinski, Benjamin Swanson, Daniel Sanchez, Andrea G. Manzanera, Estuardo Aguilar-Cordova, Mark Bloomston
Augmentation of autologous T cell reactivity with acute myeloid leukemia (AML) blasts by Toll-like receptor (TLR) agonists
RuiKun Zhong, Hongying Li, Karen Messer, Thomas A. Lane, Jiehua Zhou, Edward D. Ball
FoxP3+ and IL-17+ cells are correlated with improved prognosis in cervical adenocarcinoma
Simone Punt, Marjolein E. van Vliet, Vivian M. Spaans, Cornelis D. de Kroon, Gert Jan Fleuren, Arko Gorter, Ekaterina S. Jordanova
Impairment of lymphocyte function following yttrium-90 DOTATOC therapy
Vahé Barsegian, Christian Hueben, Stefan P. Mueller, Thorsten D. Poeppel, Peter A. Horn, Andreas Bockisch, Monika Lindemann
Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case report
Juan Martin-Liberal, Andrew JS Furness, Kroopa Joshi, Karl S. Peggs, Sergio A. Quezada, James Larkin
Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial
Lina Prasmickaite, Gisle Berge, Ingrid J. Bettum, Steinar Aamdal, Johan Hansson, Lars Bastholt, Miriam Øijordsbakken, Kjetil Boye, Gunhild M. Mælandsmo
Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model
Nana Chen, Naomi Nishio, Sachiko Ito, Yuriko Tanaka, Yang Sun, Ken-ichi Isobe